Alnylam’s Yvonne Greenstreet on RNAi and a ‘golden era’ in biotech
Talks at GS
00:00
Navigating Biotech Ambitions
This chapter explores a biotech company's aspirations to rank among the top five in the industry within five years, detailing their strategies for growth and innovation. It emphasizes the significance of their RNAi platform and the transformative impact of recent advancements in genetics and AI on drug development. Additionally, the discussion addresses the role of company culture, diversity in leadership, and the challenges of providing healthcare access in regions like Ghana.
Transcript
Play full episode
